COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION FOR ALLEVIATING ATOPIC DERMATITIS, HAIR LOSS, AND WOUNDS OR REDUCING SKIN WRINKLES
The present invention provides a cosmetic composition and a pharmaceutical composition comprising secretions of natural killer cells, which are excellent in increasing various factors related to improvement of atopic dermatitis, hair loss, wounds or skin wrinkles, and in enhancing an expression level, and thereby having excellent alleviation effects on the symptoms.
1 . A cosmetic composition for improving atopic dermatitis, hair loss, wounds or skin wrinkles, comprising secretions of natural killer cells.
2 . The composition according to claim 1 , wherein the natural killer cell secretion includes at least one selected from the group consisting of IL-2, TIMP2, VEGF, PDGF-AA and IL-10.
3 . The composition according to claim 1 , wherein the natural killer cell secretion is obtained from a residual culture liquid remaining after culturing natural killer cells and then separating and purifying the same.
4 . The composition according to claim 3 , wherein the culturing includes culturing seed cells in a medium containing feeder cells, a feeder cell stimulating factor and a growth factor.
5 . The composition according to claim 4 , wherein the seed cells are human-derived cells with a potential to differentiate into natural killer cells.
6 . The composition according to claim 5 , wherein the human-derived cell is selected from the group consisting of peripheral blood, peripheral blood leukocyte cells, peripheral blood mononuclear cells (PBMC), enriched natural killer cells, isolated natural killer cells, cord blood, hematopoietic stem cells and induced pluripotent stem cells.
7 . The composition according to claim 4 , wherein the growth factor is interleukin.
8 . A pharmaceutical composition for improving atopic dermatitis, hair loss, wounds or skin wrinkles, comprising secretions of natural killer cells.
9 . The composition according to claim 8 , wherein the natural killer cell secretion includes at least one selected from the group consisting of IL-2, TIMP2, VEGF, PDGF-AA and IL-10.
10 . The composition according to claim 8 , wherein the natural killer cell secretion is obtained from a residual culture liquid remaining after culturing natural killer cells and then separating and purifying the same.
11 . The composition according to claim 10 , wherein the culturing includes culturing seed cells in a medium containing feeder cells, a feeder cell stimulating factor and a growth factor.
12 . The composition according to claim 11 , wherein the seed cells are human-derived cells with a potential to differentiate into natural killer cells.
13 . The composition according to claim 12 , wherein the human-derived cell is selected from the group consisting of peripheral blood, peripheral blood leukocyte cells, peripheral blood mononuclear cells (PBMC), enriched natural killer cells, isolated natural killer cells, cord blood, hematopoietic stem cells and induced pluripotent stem cells.
14 . The composition according to claim 11 , wherein the growth factor is interleukin.
15 . A method for improving atopic dermatitis, hair loss, wounds or skin wrinkles in a subject, comprising administering a composition comprising a secretion of natural killer cells, wherein the secretion comprises one or more selected from the group consisting of IL-2, TIMP2, VEGF, PDGF-AA and IL-10.
16 . A method of claim 15 , wherein the composition is hair care cosmetic composition or a pharmaceutical composition.